Mycobacterium Citations List: April 2023

Literature Citations

1. Design and Synthesis of Novel Antimicrobial Agents. Breijyeh, Z. and R. Karaman. Antibiotics, 2023. 12(3): 628. PMID[36978495].
[PubMed]. TB_04_2023.

2. The Anti-aging, Anti-tuberculosis and Antioxidant Potential Benefits of Saudi Arabia Olea-europaea Leaves Extracts. El-Rahmana, S.N.A., S.A. Abubshaitb, H.A. Abubshaitc, A.M. Elsharifb, and M. Kamound. Brazilian Journal of Biology, 2023. 84: e270885. PMID[37132677].
[PubMed]. TB_04_2023.

3. Exploring the Antitubercular Activity of Anthranilic acid Derivatives: From MabA (FabG1) Inhibition to Intrabacterial Acidification. Faion, L., K. Djaout, C. Pintiala, C. Piveteau, F. Leroux, A. Biela, S. Slupek, R. Antoine, M. Zahorszka, F.X. Cantrelle, X. Hanoulle, J. Kordulakova, B. Deprez, N. Willand, A.R. Baulard, and M. Flipo. Pharmaceuticals, 2023. 16(3): 335. PMID[36986435]. PMCID[PMC10057394].
[PubMed]. TB_04_2023.

4. Synthesis of Isoniazid Analogs with Promising Antituberculosis Activity and Bioavailability: Biological Evaluation and Computational Studies. Gavadia, R., J. Rasgania, M.V. Basil, V. Chauhan, S. Kumar, and K. Jakhar. Journal of Molecular Structure, 2023. 1283: 135325. ISI[000955282900001].
[WOS]. TB_04_2023.

5. Dihydroisocoumarins and Phenylglycosides from Scorzonera longiana, Their Antimicrobial Activities and Molecular Docking Studies. Korkmaz, B., G. Renda, G. Bozdal, K. Coşkunçelebi, A. Bozdeveci, U. Uzuner, and N. Yaylı. Chemistry & Biodiversity, 2023. 20(4): e202201052. PMID[36811320].
[PubMed]. TB_04_2023.

6. Two New Dihydroisocoumarins and Terpenoids from Scorzonera longiana Sümbül an Endemic Species to Turkey and Their Antimicrobial Activity. Korkmaz, B., G. Renda, İ. Erik, G. Kılıç, K. Coşkunçelebi, and N. Yaylı. Natural Product Research, 2023. 37(7): p. 1185-1198. PMID[34736355].
[PubMed]. TB_04_2023.

7. Synthesis and Characterization of Phenylalanine amides Active against Mycobacterium abscessus and Other Mycobacteria. Lang, M., U.S. Ganapathy, L. Mann, R. Abdelaziz, R.W. Seidel, R. Goddard, I. Sequenzia, S. Hoenke, P. Schulze, W.W. Aragaw, R. Csuk, T. Dick, and A. Richter. Journal of Medicinal Chemistry, 2023. 66(7): p. 5079-5098. PMID[37001025].
[PubMed]. TB_04_2023.

8. Periphery Exploration around 2,6-Diazaspiro[3.4]octane Core Identifies a Potent Nitrofuran Antitubercular Lead. Lukin, A., K. Komarova, L. Vinogradova, M. Dogonadze, T. Vinogradova, P. Yablonsky, A. Kazantsev, and M. Krasavin. Molecules, 2023. 28(6): 2529. PMID[36985501]. PMCID[PMC10056547].
[PubMed]. TB_04_2023.

9. Anti-tuberculosis Mur Inhibitors: Structural Insights and the Way Ahead for Development of Novel Agents. Mehta, K., M. Khambete, A. Abhyankar, and A. Omri. Pharmaceuticals, 2023. 16(3): 377. PMID[36986477]. PMCID[PMC10058398].
[PubMed]. TB_04_2023.

10. 1,2,4-Triazole and Benzimidazole Fused Dihydropyrimidine Derivatives: Design, Green Synthesis, Antibacterial, Antitubercular, and Antimalarial Activities. Mokariya, J.A., D.P. Rajani, and M.P. Patel. Archiv der Pharmazie, 2023. 356(4): e2200545. PMID[36534897].
[PubMed]. TB_04_2023.

11. Nitrobenzoates and Nitrothiobenzoates with Activity against M. tuberculosis. Pais, J.P., O. Antoniuk, R. Freire, D. Pires, E. Valente, E. Anes, and L. Constantino. Microorganisms, 2023. 11(4): 969. PMID[37110393]. PMCID[PMC10142844].
[PubMed]. TB_04_2023.

12. Thermal Analysis, Antimicrobial and Antioxidant Studies of Thiosemicarbazone Derivatives. Pitucha, M., P. Ramos, K. Wojtunik-Kulesza, A. Glogowska, J. Stefanska, D. Kowalczuk, D. Monika, and E. Augustynowicz-Kopec. Journal of Thermal Analysis and Calorimetry, 2023. 148: p. 4223-4234. ISI[000943963200003].
[WOS]. TB_04_2023.

13. Quantitative UPLC-MS/MS Analysis of Obliquumol from Ptaeroxylon obliquum (Thunb.) Radlk. Extracts and Biological Activities of Its Semi-synthesised Derivative Ptaeroxylinol. Ramadwa, T.E., M.A. Selepe, M.S. Sonopo, L.J. McGaw, and J.N. Eloff. South African Journal of Botany, 2023. 156: p. 35-42. ISI[000951521400001].
[WOS]. TB_04_2023.

14. In Vitro and in Vivo Efficacy of NITD-916 against Mycobacterium fortuitum. Roquet-Banères, F., M. Alcaraz, C. Hamela, J. Abendroth, T.E. Edwards, and L. Kremer. Antimicrobial Agents & Chemotherapy, 2023. 67(4): e0160722. PMID[36920188]. PMCID[PMC10112203].
[PubMed]. TB_04_2023.

15. Natural Phytocompounds Physalin D, Withaferin A and Withanone Target L-Asparaginase of Mycobacterium tuberculosis: A Molecular Dynamics Study. Sharma, D., R. Saini, and A. Mishra. Journal of Biomolecular Structure & Dynamics, 2023. 41(7): p. 2645-2659. PMID[35132949].
[PubMed]. TB_04_2023.

16. Molecular Design and in-Silico Analysis of Trisubstituted Benzimidazole Derivatives as Ftsz Inhibitor. Thapa, S., S.L. Nargund, and M.S. Biradar. Journal of Chemistry, 2023. 2023: 9307613. ISI[000947107700001].
[WOS]. TB_04_2023.

17. Isopimarane-type Diterpenoids from the Rhizomes of Kaempferia galanga L. And Their Biological Activities. Wisetsai, A., F.T. Schevenels, S. Kanokmedhakul, K. Kanokmedhakul, J. Boonmak, S. Youngme, T. Suebrasri, and R. Lekphrom. Natural Product Research, 2023. 37(7): p. 1106-1115. PMID[34636702].
[PubMed]. TB_04_2023.

18. A New Anthraquinone from Mangrove Endophytic Fungus Aspergillus Sp. 16-5c. Xiao, Z., S. Lin, Z. She, Y. Lu, Z. Tan, and Y. Liu. Natural Product Research, 2023. 37(8): p. 1271-1276. PMID[34758689].
[PubMed]. TB_04_2023.

Patent Citations

This month, no relevant Mycobacterium patents were identified.